MOBILE VIEW  | 

SPIDERS, OTHER

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Spiders are arthropods with 8 legs, and 2 main body sections (the cephalothorax and the abdomen).
    B) All spiders, with the exception of 2 small groups, are venomous. There are over 100,000 species of spiders. At least 60 species in the United States have been implicated in producing bites (Russell & Gertsch, 1983) (Russell et al, 1974).
    1) Venomous spiders may be either large or small (Fowler, 1993). Spider venoms differ in their pharmacology and chemistry. Adverse effects are frequently local, but systemic events may occur.

Specific Substances

    A) CONSTITUENTS OF THE GROUP
    1) COMMON SPECIES THAT HAVE PRODUCED LOCAL/SYSTEMIC EFFECTS
    a) Achaearanea (Achaearanea tepidariorum)
    b) Agelenidae (Agelenopsis aptera)
    c) Amaurobiid spiders (Ixeuticus species)
    d) Banana spiders (Phoneutria & Cupiennius species)
    e) Black house spider (Badumna insignis)
    f) Breda (Breda jovialis)
    g) Combfooted (Steatoda grossa)
    h) Crab spiders (Heteropoda & Misumenoides species)
    i) Ctenid (Diallomus species)
    j) Desid (Ixeuticus species)
    k) Dysderid spiders (Dysdera species)
    l) Eriophora (Eriophora species)
    m) False black widow (Steatoda grossa)
    n) Giant crab spider (Heteropoda, Isopoda, & Olios species)
    o) Gnaphosid spider (Drassodes species)
    p) Green lynx spider (Peucetia viridans)
    q) Hackled-band spider (Filiistata species)
    r) Hadronyclids (Hadronycle adelaidensis)
    s) Hunting spider (Phoneutria species)
    t) Huntsmen spider (Sparassidae species)
    u) Jumping spiders (Phidippus, Mopsus, & Thiodina species)
    v) Lynx spider (Peucetia species)
    w) Misgolas (Misgolas andrewsi)
    x) Nephila (Nephila clavata)
    y) Opisthoncus (Opisthoncus species)
    z) Orange argiope (Argiope aurantia)
    aa) Orb weaver (Araneus, Argiope, Liocranoides, Chiracanthium, & Neoscona species)
    ab) Phonognatha (Phonognatha graeffi)
    ac) Running spider (Misumenoides, Drassodes, Lampona, Liocranoides, & Miturga species)
    ad) Sac spider (Chiracanthium)
    ae) Sicarius (Sicarius species)
    af) Tangleweb Weaver (Steatoda species)
    ag) Tarantulas (Aphonopelma, Rheostica, Pamphobeteus, & Selenocosmia species)
    ah) Trachelas (Trachelas species)
    ai) Trap door spiders (Aganippe, Arbanitis, Bothriocyrtum, Harpactirella, Hermeas, Missulena, & Ummidia species)
    aj) Wandering spiders (Cupiennius sallei)
    ak) Wolf spiders (Lycosidae; Lycosa godeffroyi)
    al) Zorid (Diallomus)
    am) SPIDER (OTHER)
    an) UNKNOWN SPIDER
    ao) SPIDER, UNKNOWN
    2) GENERA WHICH HAVE BEEN IMPLICATED IN HUMAN BITES IN THE US
    a) Agelenopsis
    b) Aphonopelma
    c) Araneus
    d) Argiope
    e) Bothriocyrtum
    f) Chiracanthium
    g) Cupiennius
    h) Drassodes
    i) Filstata
    j) Herpyllus
    k) Heteropoda
    l) Licoranoides
    m) Lycosa
    n) Misumenoides
    o) Neoscona
    p) Pamphobeteus
    q) Peucetia
    r) Phidippus
    s) Phoneutria
    t) Steatoda
    u) Thiodina
    v) Trachelas
    w) Ummidia
    3) GENERA WHICH HAVE BEEN IMPLICATED AS MILDLY ENVENOMING SPIDERS IN AUSTRALIA
    a) Achaearanea
    b) Badumna
    c) Delena
    d) Heteropoda
    e) Holconia
    f) Isopeda
    g) Isopedella
    h) Lampona
    i) Neosparassus
    j) Supunna
    4) GENERA WHICH HAVE BEEN IMPLICATED AS MILDLY ENVENOMING SPIDERS IN SOUTH AMERICA
    a) Cupiennius
    b) Lycosa
    5) GENERA WHICH HAVE BEEN IMPLICATED AS MILDLY ENVENOMING SPIDERS IN AFRICA
    a) Harpactirella lightfooti
    b) Palystes natalius
    c) Sicarius

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) EPIDEMIOLOGY: Spider bite is a relatively common call to poison centers, yet significant morbidity or mortality from a spider bite is exceedingly rare. Occasionally deaths in small children have been attributed to spider envenomation, usually from recluse spiders. Most "spider bites", however, are caused by arthropods other than spiders. Many patients presenting to Emergency Departments with "spider bites" actually have soft tissue infections. Envenomation by Latrodectus (widow spiders) and funnel web spiders, and necrotic arachnidism (brown recluse and other spiders) can cause significant local and or systemic effects; these spiders are covered in separate documents (SEE the following: SPIDER-LATRODECTUS SPECIES; NECROTIC ARACHNIDISM, or SPIDER-FUNNEL WEB as needed).
    B) TOXICOLOGY: Nearly all spiders are venomous, but very few spiders are capable of envenomating humans. Spider bites and exposures can cause clinical effects in various ways. Tarantulas, for example have hairs which cause local mucosal irritation and urticaria. Other spiders have venom containing neuromuscular toxins and venom that causes dermal necrosis. The mechanism for most spider venom has not been elucidated. There is great mechanistic venom variability across the species. Araneus venom and Nephila venom are potent glutamate receptor blockers. Nephila venom has histamine-releasing activity as well. The venom of Dugesiella hentzi (Arkansas tarantula) is a hyaluronidase. The toxin of the Joro spider likely causes selective suppression of hippocampal epileptic discharge mediated by non-N-methyl-D-aspartate receptors.
    C) WITH POISONING/EXPOSURE
    1) LOCAL EFFECTS: Macules, papules, and erythema can occur locally at the site of the bite. Pain, edema, pruritus, and urticaria are common. Vesicles that ulcerate can occur. Small areas of necrosis may develop. Secondary infections are not common. Ophthalmia nodosa, local eye irritation, and allergic rhinitis can occur after handling tarantula hairs.
    2) SYSTEMIC EFFECTS: Systemic involvement is rare. Nausea and abdominal cramping, anxiety, lymphangitis, headache, and malaise have been reported. Bites from Phoneutria species (wandering or banana spiders) can occasionally cause diaphoresis, agitation, salivation, priapism, and hypotension.
    0.2.3) VITAL SIGNS
    A) WITH POISONING/EXPOSURE
    1) Alterations in temperature (subnormal and above) have been reported after spider bites.
    0.2.4) HEENT
    A) OPHTHALMIA NODOSA has been reported after handling tarantula spiders.
    B) Eye irritation can also occur following contact with squashed spider parts.
    0.2.7) NEUROLOGIC
    A) WITH POISONING/EXPOSURE
    1) Neurogenic shock has been seen after spider bite. Anxiety is common, and occasionally headache, weakness, and malaise will be seen.
    0.2.8) GASTROINTESTINAL
    A) WITH POISONING/EXPOSURE
    1) The most common GI symptom is nausea. Less commonly, abdominal cramping, diarrhea, and excessive salivation are seen.
    0.2.10) GENITOURINARY
    A) WITH POISONING/EXPOSURE
    1) Priapism is rare.
    0.2.14) DERMATOLOGIC
    A) WITH POISONING/EXPOSURE
    1) Macule/papule formation occurs after bites by some spiders. Pain, edema, pruritus, and erythema are common. Some bites produce necrotic tissues. Urticaria may occur after tarantula exposure. Lymphangitis is an uncommon complication.
    0.2.15) MUSCULOSKELETAL
    A) WITH POISONING/EXPOSURE
    1) Muscular cramping is seen in the abdomen, throat, back, and extremities after black widow bites. Arthralgia is rarely seen. Myalgia has been reported following other spider bites.
    0.2.19) IMMUNOLOGIC
    A) WITH POISONING/EXPOSURE
    1) Urticaria may occur; anaphylaxis is rare. Immunopathologic changes have been seen after multiple spider bites.
    0.2.22) OTHER
    A) Tularemia may be carried by spiders.

Laboratory Monitoring

    A) No specific laboratory studies are needed in most patients. For symptomatic patients, monitor CBC, serum electrolytes and renal function.

Treatment Overview

    0.4.4) EYE EXPOSURE
    A) DECONTAMINATION: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, the patient should be seen in a healthcare facility.
    0.4.7) BITES/STINGS
    A) MILD TO MODERATE ENVENOMATION
    1) Management of most spider bites and exposures is supportive. For eye exposures, irrigate with copious amounts of normal saline for 15 minutes. Bites to the skin typically require local wound care and cleansing. Cool compresses may help with irritation, antihistamines with itching, and oral pain medications are usually adequate to relieve discomfort. Evaluate for evidence of abscess or cellulitis. Remove tarantula hairs from the skin and clothing, irrigate exposed eyes.
    B) SEVERE ENVENOMATION
    1) Treat allergic reactions with antihistamines, steroids and epinephrine. Treat agitation with benzodiazepines and nausea/vomiting with antiemetics.
    C) ANTIDOTE
    1) There is an antiarachnid antivenom that has been reported to be effective for Phoneutria nigriventer which is a spider found in Brazil.
    D) PATIENT DISPOSITION
    1) HOME CRITERIA: Patients experiencing local reactions, signs, and symptoms from a spider bite can provide wound care at home themselves. The mainstay of therapy is local wound care and wound cleaning.
    2) OBSERVATION CRITERIA: Patients with severe pain, significant allergic reactions or more than mild systemic symptoms should be evaluated at a health care facility.
    3) ADMISSION CRITERIA: Patients with bites from spiders other than Latrodectus (widow), recluse (violin) or Atrax (funnel web) rarely require admission. If severe symptoms develop, the diagnosis should be reconsidered.
    4) CONSULT CRITERIA: Consult a poison center or medical toxicologist for assistance in managing patients with severe signs and symptoms or in whom the diagnosis is unclear.
    E) DIFFERENTIAL DIAGNOSIS
    1) Arthropod bites other than spiders may occur, which may be difficult to distinguish (ie, clinical evidence, symptoms) from a spider bite. Fleas, bed bugs, ticks, mites, hymenoptera stings, and biting flies are much more common and may produce wounds that are confused with those created by spiders. Cellulitis or skin abscesses (especially methicillin-resistant staph) may appear similar to local effects from spider envenomations.
    F) PITFALLS
    1) Patients with bites from spiders other than Latrodectus (widow), recluse (violin) or Atrax (funnel web) rarely develop significant systemic or local effects. If severe symptoms develop, the diagnosis should be reconsidered. Most patients (80% or more) who present to a hospital complaining of a "spider bites" are ultimately found to have some other condition.
    G) LATRODECTUS/BLACK WIDOW
    1) Refer to "SPIDER-LATRODECTUS SPECIES" management.
    H) LOXOSCELES
    1) Refer to "NECROTIC ARACHNIDISM" management.

Range Of Toxicity

    A) TOXICITY: Systemic toxicity is rare, and deaths from these spiders are not described.

Summary Of Exposure

    A) EPIDEMIOLOGY: Spider bite is a relatively common call to poison centers, yet significant morbidity or mortality from a spider bite is exceedingly rare. Occasionally deaths in small children have been attributed to spider envenomation, usually from recluse spiders. Most "spider bites", however, are caused by arthropods other than spiders. Many patients presenting to Emergency Departments with "spider bites" actually have soft tissue infections. Envenomation by Latrodectus (widow spiders) and funnel web spiders, and necrotic arachnidism (brown recluse and other spiders) can cause significant local and or systemic effects; these spiders are covered in separate documents (SEE the following: SPIDER-LATRODECTUS SPECIES; NECROTIC ARACHNIDISM, or SPIDER-FUNNEL WEB as needed).
    B) TOXICOLOGY: Nearly all spiders are venomous, but very few spiders are capable of envenomating humans. Spider bites and exposures can cause clinical effects in various ways. Tarantulas, for example have hairs which cause local mucosal irritation and urticaria. Other spiders have venom containing neuromuscular toxins and venom that causes dermal necrosis. The mechanism for most spider venom has not been elucidated. There is great mechanistic venom variability across the species. Araneus venom and Nephila venom are potent glutamate receptor blockers. Nephila venom has histamine-releasing activity as well. The venom of Dugesiella hentzi (Arkansas tarantula) is a hyaluronidase. The toxin of the Joro spider likely causes selective suppression of hippocampal epileptic discharge mediated by non-N-methyl-D-aspartate receptors.
    C) WITH POISONING/EXPOSURE
    1) LOCAL EFFECTS: Macules, papules, and erythema can occur locally at the site of the bite. Pain, edema, pruritus, and urticaria are common. Vesicles that ulcerate can occur. Small areas of necrosis may develop. Secondary infections are not common. Ophthalmia nodosa, local eye irritation, and allergic rhinitis can occur after handling tarantula hairs.
    2) SYSTEMIC EFFECTS: Systemic involvement is rare. Nausea and abdominal cramping, anxiety, lymphangitis, headache, and malaise have been reported. Bites from Phoneutria species (wandering or banana spiders) can occasionally cause diaphoresis, agitation, salivation, priapism, and hypotension.

Vital Signs

    3.3.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Alterations in temperature (subnormal and above) have been reported after spider bites.
    3.3.3) TEMPERATURE
    A) WITH POISONING/EXPOSURE
    1) SUMMARY: Both subnormal and above normal temperatures have been seen. Neither chills nor fever is a common symptom unless infection is involved.
    2) SUBNORMAL TEMPERATURE
    a) Subnormal temperature has occurred after spider bites.
    b) CHIRACANTHIUM SPECIES: Subnormal temperature has been reported (Russell, 1991).
    3) ELEVATED TEMPERATURE
    a) Elevated temperature has been seen after spider bites. Fever was reported in 5 of 9 patients bitten by pet tarantulas in one series (De Haro & Jouglard, 1998).
    b) STEATODA NOBILIS produced a neurotoxin bite with flushing and fever (Warrell et al, 1991).

Heent

    3.4.1) SUMMARY
    A) OPHTHALMIA NODOSA has been reported after handling tarantula spiders.
    B) Eye irritation can also occur following contact with squashed spider parts.
    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) OPHTHALMIA NODOSA has been reported after handling tarantula spiders (Hered et al, 1988). Care should be taken when handling or cleaning cages of pet tarantulas, to avoid contact with the urticating hairs (Kelley & Wasserman, 1998).
    2) Eye irritation (intense pain with severe scleral and conjunctival swelling) can also occur following contact with squashed spider parts. In addition, a clear gelatinous discharge causing blurred vision was noted (Grebert, 2004; Isbister, 2003).
    3) CASE REPORT: A 46-year-old man reported severe pain, redness, and swelling immediately after squashing a huntsman spider with a newspaper, getting spider material near his eye, then rubbing his eye. Conjunctival edema, redness, periorbital edema, and severe photophobia were noted during a hospital evaluation. He was treated with topical anesthetic, copious eye irrigation, antibiotic eye ointment, and an eye patch. Symptoms were resolved upon recheck 28 hours later (Isbister, 2003). Similar cases reporting eye irritation from squashed daddy long legs spiders have also been reported (Grebert, 2004; Isbister & Balit, 2001).
    3.4.5) NOSE
    A) WITH POISONING/EXPOSURE
    1) TARANTULAS: Allergic rhinitis may develop after inhalation of the hairs from pet tarantulas (Kelley & Wasserman, 1998).

Neurologic

    3.7.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Neurogenic shock has been seen after spider bite. Anxiety is common, and occasionally headache, weakness, and malaise will be seen.
    3.7.2) CLINICAL EFFECTS
    A) CENTRAL NERVOUS SYSTEM FINDING
    1) WITH POISONING/EXPOSURE
    a) Signs and symptoms include cold profuse sweating, agitation, salivation, priapism, and death. This condition has been seen in children after bites by Phoneutria species spiders (Lucas, 1988). Similar symptoms were reported in an adult following a moderate to severe envenomation by a P nigriventer female spider; symptoms rapidly resolved with antivenom administration (Bucaretchi et al, 2008).
    B) HEADACHE
    1) WITH POISONING/EXPOSURE
    a) Headache has occurred after some spider bites.
    b) CHIRACANTHIUM SPECIES: Headache has been reported (Russell, 1991).
    c) STEATODA SPECIES: Systemic symptoms, including headache, malaise, and lethargy, occurred in several patients following Steatoda spider bites (Isbister & Gray, 2003).
    C) ANXIETY
    1) WITH POISONING/EXPOSURE
    a) Anxiety is common after spider bites.
    b) CHIRACANTHIUM SPECIES: Anxiety has been reported (Russell, 1991).
    c) BADUMNA INSIGNIS: Anxiety, pain, sweating, and nausea were reported following envenomation by a black house spider (Badumna insignis) (Woo & Smart, 1999).
    D) MALAISE
    1) WITH POISONING/EXPOSURE
    a) Malaise is occasionally reported after spider bite.
    b) HERPYLLUS ECCLESIASTICUS: An adult bitten on the shoulder experienced malaise and other symptoms. Signs resolved within 9 days (Majeski & Durst, 1975).
    c) STEATODA SPECIES: Systemic symptoms, including malaise, lethargy, and headache, occurred in several patients following Steatoda spider bites (Isbister & Gray, 2003).
    d) THIODINA SPECIES: An adult bitten on the thigh experienced weakness (Waldron, 1968).

Gastrointestinal

    3.8.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) The most common GI symptom is nausea. Less commonly, abdominal cramping, diarrhea, and excessive salivation are seen.
    3.8.2) CLINICAL EFFECTS
    A) EXCESSIVE SALIVATION
    1) WITH POISONING/EXPOSURE
    a) Salivation is rare.
    b) PHONEUTRIA SPECIES: Excessive salivation occurred in children after Phoneutria spider bites (Lucas, 1988).
    B) NAUSEA AND VOMITING
    1) WITH POISONING/EXPOSURE
    a) Nausea has occurred after some spider bites.
    b) BADUMNA INSIGNIS: Nausea was reported following a bite from a black house spider (Badumna insignis) (Woo & Smart, 1999).
    c) CHIRACANTHIUM SPECIES: Nausea and abdominal cramps have been reported (Russell, 1991). The nausea and abdominal distress usually subside within 24 hours.
    d) HERPYLLUS ECCLESIASTICUS: An adult bitten on the shoulder experienced nausea. Symptoms resolved within 9 days (Majeski & Durst, 1975).
    e) LYCOSA SPECIES: A Lycosa miami bite produced transient light-headedness and nausea (Grothaus & Teller, 1968).
    f) PHONEUTRIA SPECIES: Vomiting was reported in 1 adult following a bite by a Phoneutria nigriventer (Bucaretchi et al, 2008).
    g) STEATODA SPECIES: Nausea and vomiting have been reported in several patients with Steatoda spider bites (Isbister & Gray, 2003; Graudins et al, 2002).
    h) TRACHELAS SPECIES: Bites may cause nausea and pain (Uetz, 1973).
    C) DIARRHEA
    1) WITH POISONING/EXPOSURE
    a) Diarrhea is rare.
    b) THIODINA SPECIES: An adult bitten on the thigh experienced diarrhea (Waldron, 1968).

Genitourinary

    3.10.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Priapism is rare.
    3.10.2) CLINICAL EFFECTS
    A) PRIAPISM
    1) WITH POISONING/EXPOSURE
    a) Priapism occurred in children after Phoneutria spider bites (Lucas, 1988). It was also reported in an adult following a bite by a P nigriventer female spider (Bucaretchi et al, 2008).

Dermatologic

    3.14.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Macule/papule formation occurs after bites by some spiders. Pain, edema, pruritus, and erythema are common. Some bites produce necrotic tissues. Urticaria may occur after tarantula exposure. Lymphangitis is an uncommon complication.
    3.14.2) CLINICAL EFFECTS
    A) ERUPTION
    1) WITH POISONING/EXPOSURE
    a) Erythema occurs with many bites, including those from the Lycosidae (wolf spiders) (Campbell et al, 1987) (Wong et al, 1987).
    b) ACHAEARANEA SPECIES: Localized erythema, without swelling, occurred in 4 of 5 patients who were bitten by Achaearanea species of spiders (Isbister & Gray, 2003).
    c) STEATODA SPECIES: An erythematous, indurated patch, approximately 10 cm in diameter, occurred at the bite site of a woman who was bitten on the left shoulder blade by a Steatoda grossa spider (Graudins et al, 2002).
    d) CHEIRACANTHIUM SPECIES: In a retrospective review of 20 cases of confirmed Cheiracanthium spider bites, pain (intense; similar to a bee sting), redness and swelling at the site were common. Itching was also relatively common in bites by C mildei and C inclusum species. Two cases of systemic effects including nausea, vomiting, and headache were reported. No cases of dermonecrotic lesions were observed (Vetter et al, 2006).
    B) LYMPHANGITIS
    1) WITH POISONING/EXPOSURE
    a) Lymphangitis may occur after some spider bites, but is an uncommon complication.
    b) LYCOSA SPECIES: In one case, a lymphangitis occurred after 3 days. It was treated with antibiotics (Redman, 1974).
    C) SKIN NECROSIS
    1) WITH POISONING/EXPOSURE
    a) Indolent ulcers are seen after some spider bites, especially bites of Loxosceles (violin) spiders (Kunkel, 1988). See the "NECROTIC ARACHNIDISM" management, if a Loxosceles spider bite is suspected.
    1) LOXOSCELES: Reports of necrotic or gangrenous arachnidism attributed to Loxosceles species may also be traceable to other spider species or ticks. This is especially true in areas where Loxosceles is NOT endemic.
    2) INCIDENCE: One hospital reported 55 cases of necrotic arachnidism over 10 years. Bites were caused by a variety of spiders, with varying severity. Some warranted hospitalization.
    b) ARGIOPE ARGENTATA: Bites produce a sharp pain, erythema, and vesicle formation (Minton, 1972). Necrotic lesions have also been reported (Anderson, 1982).
    c) CHIRACANTHIUM SPECIES: A small vesicle may form. Small petechiae may appear near the center of the weal. A crust forms, with a necrotic area underneath, and redness and swelling surrounding the bite site (Alexander, 1984) (Minton, 1972) (Furman & Reeves, 1957).
    1) The macule at the bite site may persist for several days. The bite site gradually heals within a month (Waldron, 1965; Russell & Waldron, 1967; Spielman & Levi, 1970).
    2) A more recent retrospective review of confirmed cases of Cheiracanthium spp. bites resulted in NO dermonecrotic lesions (Vetter et al, 2006).
    d) LAMPONA SPECIES: Blistering, ulceration, pain, and skin necrosis were found in 14 cases of spider bites thought to be from the white-tailed spider (note: only 3 cases were confirmed). One patient required amputation of the hand and distal forearm. In 9 of the patients, the necrosis recurred (Pincus et al, 1999). Another patient had 2 recurrences of necrotic arachnidism in the 12 months following a bite by a white-tailed spider (Chan, 1998).
    e) LYCOSA SPECIES: Bites from these spiders produce a laceration at the bite site, and the area may become necrotic (Anderson, 1982) (Russell & Waldron, 1967)(Minton, 1972). In one case, sloughing of necrotic skin was observed in 1 week (Redman, 1974).
    f) PEUCETIA VIRIDANS: Bites sometimes produce a pustule-like sore that develops into a small ulceration. The sore heals over several days, without treatment (Wong et al, 1987; Hall & Madon, 1973).
    g) STEATODA SPECIES: Bites may give rise to a syndrome similar to that seen following Loxosceles bites. In the US, bites generally do not produce more than local pain, induration, pruritus, and the near breakdown of tissue at the bite site (Russell, 1991).
    D) EDEMA
    1) WITH POISONING/EXPOSURE
    a) Edema, erythema, and pruritus are common findings after spider bites.
    b) ARGIOPE SPECIES: The bite produces a momentary sharp pain, followed by swelling and erythema (Gorham & Rheney, 1968).
    c) BADUMNA INSIGNIS: White et al (1989) reported 5 bites that produced a mild sting to sharp pain for a short duration, followed by redness, pruritus, and edema at the bite site.
    d) CHIRACANTHIUM SPECIES: Pain from the bite may persist for several hours (Russell, 1991). An erythematous wheal appears within 30 minutes, and pruritus is common. Skin temperature at the bite site is elevated.
    e) DELENA CANCERIDES: A bite from a huntsman spider (Delena cancerides) resulted in a swollen, erythematous, and tender bite site, with pain radiating up the affected extremity. The patient recovered following administration of antihistamines (Woo & Smart, 1999).
    f) HERPYLLUS ECCLESIASTICUS: An adult bitten on the shoulder experienced sharp pain, itching, erythema, and swelling at the site. Signs resolved within 9 days (Majeski & Durst, 1975).
    g) ISOPEDA SPECIES: These spider bites produced only local symptoms of slight pain, stinging, and erythema for less than 30 minutes (White et al, 1989).
    h) LYCOSA SPECIES: Bites cause pain, erythema, and edema. There may be a laceration at the bite site (Russell & Waldron, 1967)(Minton, 1972). In one case, it took 6 days for the swelling to subside, and 10 days for the pain to stop (Redman, 1974).
    i) PEUCETIA VIRIDANS: Bites produce a stinging sensation followed by burning and itching. An area up to 20 cm in diameter may become red and swollen. The sore heals over several days, without treatment (Wong et al, 1987; Hall & Madon, 1973).
    j) PHIDIPPUS SPECIES: Bites produce pain, erythema, pruritus, and swelling. Swelling may become severe, and involve the entire hand, when only a finger has been bitten. The swelling usually subsides within 48 hours (Russell, 1991), but may last up to 2 weeks (Wong et al, 1987) (Russell, 1970).
    k) STEATODA SPECIES: Erythema at the bite site and localized swelling occurred in 96% and 9% of the patients (n=23), respectively, following envenomation by Steatoda species spiders (Isbister & Gray, 2003).
    l) TARANTULA: Bites can be almost painless or produce a deep, throbbing pain for an hour or so (Hunt, 1981; Wong et al, 1987). In one series, pain and local swelling were reported in several patients bitten by pet tarantulas (De Haro & Jouglard, 1998).
    m) THIODINA SPECIES: An adult bitten on the thigh experienced a brief, immediate pain, followed by some itching and ecchymotic edema that gradually subsided over 2 weeks (Waldron, 1968).
    n) TRACHELAS SPECIES: Bites generally cause local stinging and pain, with some slight swelling. All cases have resolved within 3 weeks (Wong et al, 1987). An adult developed facial swelling and a probable secondary infection that required penicillin. Symptoms resolved over 7 days (Uetz, 1973).
    E) URTICARIA
    1) WITH POISONING/EXPOSURE
    a) Urticaria is often seen with tarantulas. A number of species have urticaria-inducing hairs on the back of the abdomen (King, 1987). Contact may cause itching and wheals that persist for weeks.
    b) The tarantulas may flick these hairs toward an aggressor as a defensive mechanism. The pet store tarantula is especially prone to produce edema and itching due to these hairs (Gertsch, 1979)( Cooke et al, 1973) (Kelley & Wasserman, 1998).
    F) PAIN
    1) WITH POISONING/EXPOSURE
    a) ACHAEARANEA SPECIES: Five patients who received Achaearanea spider bites experienced pain in all instances, with 3 of the patients reporting severe pain and 2 the patients reporting radiating pain in the proximal limb. The median duration of pain was 16 hours (interquartile range from 4 to 24 hours); however, 2 of the 5 patients reported pain lasting at least 24 hours (Isbister & Gray, 2003).
    b) STEATODA SPECIES: A prospective cohort study, identifying bites from Steatoda species of spiders, reported the occurrence of pain, sometimes severe, in all patients (n=23). The median duration of pain was 6 hours (interquartile range from 1 to 12 hours); however, 4 patients (17%) reported the duration of pain lasting at least 24 hours after Steatoda species envenomation. Three patients (13%) reported radiating pain of the affected extremity and 2 patients (9%) reported abdominal and/or chest pain (Isbister & Gray, 2003).
    1) CASE REPORT: A 37-year-old man experienced severe pain that radiated to his knee and groin after being bitten on the toe by a Steatoda species spider. A red mark was observed at the bite site, and the patient also experienced nausea. Because the spider was misidentified as a red-back spider (Latrodectus), the patient received red-back spider antivenom intravenously approximately 4 hours after envenomation. The pain completely resolved 1 hour after administration of the antivenom. It is speculated that the red-back spider antivenom may be cross-reactive with Steatoda venom (Isbister & Gray, 2003).
    2) CASE REPORT: A 22-year-old woman received a spider bite on her left shoulder blade, and, 10 minutes later, experienced localized pain that rapidly spread to her left arm and chest. Within 4 to 5 hours of the bite, the patient also developed hot and cold flushes, nausea, and vomiting. Physical examination showed an erythematous, indurated area, approximately 10 cm in diameter, on her left shoulder blade. Despite identification of the spider as a Steatoda species, the patient was given red-back spider antivenom (RBSAV) because of her symptom similarities to latrodectism typically seen with red-back spider (Latrodectus hasselti) envenomation. After 2 doses of RBSAV, the patient's chest and regional pain completely resolved (Graudins et al, 2002). The authors suggest that the Steatoda venom may be antigenically similar to Latrodectus hasselti venom and the alpha-Latrotoxin found in L hasselti venom, thereby responding to the administration of RBSAV.
    c) CHEIRACANTHIUM SPECIES: In a retrospective review of 20 cases of confirmed Cheiracanthium spider bites, pain (intense; similar to a bee sting), redness, and swelling at the site were common. Itching was also relatively common in bites by C mildei and C inclusum species. Two cases of systemic effects including nausea, vomiting, and headache were reported. No cases of dermonecrotic lesions were observed (Vetter et al, 2006).
    d) PHONEUTRIA SPECIES: A 52-year-old man was bitten on the neck by a P nigriventer female spider (8 cm long) and developed immediate, intense, nonradiating pain, followed by blurred yellow vision, profuse sweating, priapism, tremors, and an episode of vomiting. Upon admission, the patient was agitated, with a blood pressure of 200/130 mmHg, and generalized tremors and local erythema at the site. Approximately 4 hours after envenomation, the patient received 5 vials of undiluted antiarachnid antivenom (Instituto Butantan, Sao Paulo, Brazil), and 2% lidocaine was used to treat localized pain. Within 1 hour, most of the patient's clinical symptoms had resolved (Bucaretchi et al, 2008).

Musculoskeletal

    3.15.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Muscular cramping is seen in the abdomen, throat, back, and extremities after black widow bites. Arthralgia is rarely seen. Myalgia has been reported following other spider bites.
    3.15.2) CLINICAL EFFECTS
    A) JOINT PAIN
    1) WITH POISONING/EXPOSURE
    a) Spider bites occasionally cause arthralgia.
    b) HERPYLLUS ECCLESIASTICUS: Arthralgias has been reported. Signs resolved within 9 days (Majeski & Durst, 1975).

Immunologic

    3.19.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Urticaria may occur; anaphylaxis is rare. Immunopathologic changes have been seen after multiple spider bites.
    3.19.2) CLINICAL EFFECTS
    A) ANAPHYLACTOID REACTION
    1) WITH POISONING/EXPOSURE
    a) Anaphylactoid reaction is a RARE reaction in humans (Fowler, 1993). Reactions have been reported more in the European literature after repeated exposures (King, 1987).
    B) DISORDER OF IMMUNE FUNCTION
    1) WITH POISONING/EXPOSURE
    a) Decreases in C4 (complement 4) occurred at day 3 postbite, and had almost returned to normal in 3 weeks. Elevated circulating immune complexes were also noted (Maso et al, 1987).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) No specific laboratory studies are needed in most patients. For symptomatic patients, monitor CBC, serum electrolytes and renal function.
    4.1.2) SERUM/BLOOD
    A) OTHER
    1) Laboratory studies are not indicated in most patients.
    a) Based on an adult with a moderate to severe Phoneutria nigriventer envenomation, laboratory values were essentially normal (Bucaretchi et al, 2008).

Methods

    A) ELISA
    1) PHONEUTRIA NIGRIVENTER: Circulating venom was measured by enzyme-linked immunosorbent assay (ELISA) in an adult following a P nigriventer moderate to severe envenomation in the neck. A level of 47.5 ng/mL was detected shortly after admission, with no venom detected after antivenom was given. The authors were unsure if this was due to an inability of the assay to detect low levels of venom or that the venom rapidly cleared the patient's circulation (Bucaretchi et al, 2008).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.6) DISPOSITION/BITE-STING EXPOSURE
    6.3.6.1) ADMISSION CRITERIA/BITE-STING
    A) Patients with bites from spiders other than Latrodectus (widow), recluse (violin) or Atrax (funnel web) rarely require admission. If severe symptoms develop, the diagnosis should be reconsidered.
    6.3.6.2) HOME CRITERIA/BITE-STING
    A) Patients experiencing local reactions, signs, and symptoms from a spider bite can provide wound care at home themselves. The mainstay of therapy is local wound care and wound cleaning.
    6.3.6.3) CONSULT CRITERIA/BITE-STING
    A) Consult a poison center or medical toxicologist for assistance in managing patients with severe signs and symptoms or in whom the diagnosis is unclear.
    6.3.6.5) OBSERVATION CRITERIA/BITE-STING
    A) Patients with severe pain, significant allergic reactions or more than mild systemic symptoms should be evaluated at a health care facility.

Monitoring

    A) No specific laboratory studies are needed in most patients. For symptomatic patients, monitor CBC, serum electrolytes and renal function.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) FIRST AID
    1) Most treatment is symptomatic and supportive. Bites to the skin typically requires local wound care and cleansing. Cool compresses may help with irritation, antihistamines with itching, and oral pain medications are usually adequate to relieve discomfort.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).
    B) Topical eye anesthetic may be useful prior to eye irrigation.
    6.8.2) TREATMENT
    A) SUPPORT
    1) Treatment of eye irritation following contact with spiders is generally symptomatic and supportive.
    2) Topical eye antibiotics and eye patching may be beneficial following eye irrigation.

Summary

    A) TOXICITY: Systemic toxicity is rare, and deaths from these spiders are not described.

Minimum Lethal Exposure

    A) SUMMARY
    1) The bite of these spiders is very rarely lethal.

Maximum Tolerated Exposure

    A) SUMMARY
    1) One spider bite may produce symptoms.
    B) PHONEUTRIA NIGRIVENTER
    1) The P nigriventer is found in Brazil. There are limited reports of envenomations in humans, with most reports occurring in children.
    a) CASE REPORT: A 52-year-old man was bitten on the neck by a Phoneutria nigriventer female spider (8 cm long) and developed moderate to severe symptoms, which included intense pain and erythema at the bite site, along with profuse sweating, blurred yellow vision, agitation, priapism, tremors, and an episode of vomiting. Laboratory levels were essentially normal. Signs and symptoms resolved within an hour of antivenom administration (Bucaretchi et al, 2008).

Toxicologic Mechanism

    A) Spider venoms vary considerably in chemistry and pharmacology.
    1) ARANEUS VENOM is found to be a potent blocker of glutamate receptors (Early & Michaelis, 1987).
    2) DUGESIELLA HENTZI VENOM: The venom of the Arkansas tarantula consists primarily of hyaluronidase and a protein that is toxic to cockroaches (Wong et al, 1987).
    3) JORO SPIDER TOXIN: An analogue of this toxin, called 1-napthylacetyl spermine, has shown selective suppression of hippocampal epileptic discharges mediated by non-N-methyl-D-asparate receptors (Kani et al, 1992).
    4) LATRODECTUS VENOM has an effect on neuromuscular transmission
    5) LOXOSCELES VENOM produces local tissue changes.
    6) NEPHILA VENOM: N clavata and N maculata venoms are potent blockers of glutamate receptors (Kawai & Nakajima, 1990). N clavata venom has been found to have histamine-releasing activity (Toki et al, 1988).
    7) STEATODA VENOM
    a) Steatoda paykulliana is a spider that is frequently mistaken for the black widow. Its venom does not contain alpha latrotoxin and will not cross-react with black widow venom.
    b) This venom does cause increased porosity of membranes, and it contains a high molecular weight protein that is toxic to houseflies (Cavalieri et al, 1987).
    8) OTHERS: The mechanisms of action of most other spider venoms have not been determined.
    B) SPARASSIDAE SPECIES: The mechanism of effect in this species appears to be trauma rather than envenomation (Isbister & Hirst, 2003).

Clinical Effects

    11.1.5) EQUINE/HORSE
    A) IXEUTICUS ROBUSTUS: A horse stabled in a stall known to be frequented by the black house spider developed hot, edematous, and painful swellings around the head and neck (Pascoe, 1973).
    11.1.13) OTHER
    A) OTHER
    1) Spider bites are seldom seen in large animals, although they certainly happen. They are most often diagnosed based on preconceived ideas of the signs that should be produced by a spider bite (Fowler, 1993). Localized necrotic areas may occur with bites of spiders such as Loxosceles.

Treatment

    11.2.1) SUMMARY
    A) GENERAL TREATMENT
    1) Remove the patient and other animals from the spider-infested area, if possible.
    2) Treatment should always be done on the advice and with the consultation of a veterinarian.
    3) Additional information regarding treatment of poisoned animals may be obtained from a Board Certified (ABVT) Veterinary Toxicologist (check with nearest veterinary school or veterinary diagnostic laboratory) or the National Animal Poison Control Center.
    4) ANIMAL POISON CONTROL CENTERS
    a) ASPCA Animal Poison Control Center, An Allied Agency of the University of Illinois, 1717 S. Philo Rd, Suite 36, Urbana, IL 61802, website www.aspca.org/apcc
    b) It is an emergency telephone service which provides toxicology information to veterinarians, animal owners, universities, extension personnel and poison center staff for a fee. A veterinary toxicologist is available for consultation.
    c) The following 24-hour phone number is available: (888) 426-4435. A fee may apply. Please inquire with the poison center. The agency will make follow-up calls as needed in critical cases at no extra charge.
    11.2.4) DECONTAMINATION
    A) GASTRIC DECONTAMINATION
    1) GENERAL TREATMENT
    a) Remove the offending spider if it is still on the animal.

Continuing Care

    11.4.1) SUMMARY
    11.4.1.2) DECONTAMINATION/TREATMENT
    A) GENERAL TREATMENT
    1) Remove the patient and other animals from the spider-infested area, if possible.
    2) Treatment should always be done on the advice and with the consultation of a veterinarian.
    3) Additional information regarding treatment of poisoned animals may be obtained from a Board Certified (ABVT) Veterinary Toxicologist (check with nearest veterinary school or veterinary diagnostic laboratory) or the National Animal Poison Control Center.
    4) ANIMAL POISON CONTROL CENTERS
    a) ASPCA Animal Poison Control Center, An Allied Agency of the University of Illinois, 1717 S. Philo Rd, Suite 36, Urbana, IL 61802, website www.aspca.org/apcc
    b) It is an emergency telephone service which provides toxicology information to veterinarians, animal owners, universities, extension personnel and poison center staff for a fee. A veterinary toxicologist is available for consultation.
    c) The following 24-hour phone number is available: (888) 426-4435. A fee may apply. Please inquire with the poison center. The agency will make follow-up calls as needed in critical cases at no extra charge.
    11.4.2) DECONTAMINATION
    11.4.2.2) GASTRIC DECONTAMINATION
    A) GASTRIC DECONTAMINATION
    1) GENERAL TREATMENT
    a) Remove the offending spider if it is still on the animal.

General Bibliography

    1) Anderson PC: Necrotizing spider bites. Am Fam Physician 1982; 26:198-203.
    2) Auer AI & Hershey FB: Surgery for necrotic bites of the brown spider. Arch Surg 1974; 108:612-618.
    3) Barron WE: Spider bites. J Med Assoc Georgia 1960; 49:511-512.
    4) Bucaretchi F, Mello SM, Vieira RJ, et al: Systemic envenomation caused by the wandering spider Phoneutria nigriventer, with quantification of circulating venom. Clin Toxicol (Phila) 2008; 46(9):885-889.
    5) Bush SP, Giem P, & Vetter RS: Green Lynx Spider (Peucetia viridans) envenomation. Am J Emerg Med 2000; 18:64-66.
    6) Chan S: Recurrent necrotising arachnidism [letter]. Med J Aust 1998; 169:642-643.
    7) Chew P: FAMILY PHOLCIDAE- Daddy long-leg Spiders. Peter Chew. Brisbane, Australia. 2005. Available from URL: http://www.geocities.com/brisbane_weavers/Pholcidae.htm. As accessed 2009-01-20.
    8) Commonwealth Scientific and Industrial Research Organisation: Mouse Spider. Commonwealth Scientific and Industrial Research Organisation. Clayton South VIC, Australia. 2008. Available from URL: http://www.csiro.au/resources/Mouse-Spider.html. As accessed 2009-01-20.
    9) De Haro L & Jouglard J: The dangers of pet tarantulas: experience of the Marseilles Poison Centre (letter). Clin Toxicol 1998; 36:51-53.
    10) Denny WF, Dillaha J, & Morgan PN: Hemolytic effect of Loxosceles reclusus venom: In vivo and in vitro studies. J Lab Clin Med 1964; 64:291-298.
    11) Diaz JH & Leblanc KE: Common spider bites. Am Fam Physician 2007; 75(6):869-873.
    12) Diaz JH: The global epidemiology, syndromic classification, management, and prevention of spider bites. Am J Trop Med Hyg 2004; 71(2):239-250.
    13) Fardon DW, Wingo CW, & Robinson DW: The treatment of brown spider bite. Plast Reconstr Surg 1967; 40:482-488.
    14) Fowler ME: Veterinary Zootoxicology, CRC Press, Boca Raton, Florida, 1993.
    15) Gorham JR & Rheney TB: Envenomation by ths spiders Chiracanthium inclusum and Argiope aurantia. JAMA 1968; 206:1958-1962.
    16) Graudins A, Gunja N, Broady KW, et al: Clinical and in vitro evidence for the efficacy of Australian red-back spider (Latrodectus hasselti) antivenom in the treatment of envenomation by a Cupboard spider (Steatoda grossa). Toxicon 2002; 40:767-775.
    17) Grebert N: Squashed spiders in the eyes. Aust Family Physician 2004; 33(3):103-104.
    18) Grothaus RH & Teller LW: Envenomization by the spider Lycosa miami Wallace. J Med Entomol 1968; 5:500.
    19) Hall RE & Madon MB: Envenomation by the green lynx spider Peucetia viridans (Hentz 1932), in Orange County, California. Toxicon 1973; 11:197-199.
    20) Hered RW, Spaulding AG, & Sanitato JJ: Ophthalmia nodosa caused by tarantula hairs. Ophthalmology 1988; 95:166-169.
    21) Hunt GR: Bites and stings of uncommon arthropods. I. Spiders. Postgrad Med 1981; 70:91-102.
    22) Isbister GK & Balit C: Eye exposure to squashed spiders. Med J Aust 2001; 175:391-392.
    23) Isbister GK & Gray MR: Effects of envenoming by comb-footed spiders of the genera Steatoda and Achaearanea (family Theridiidae: Araneae) in Australia. J Toxicol Clin Toxicol 2003; 41:809-819.
    24) Isbister GK & Hirst D: A prospective study of definite bites by spiders of the family Sparassidae (huntsmen spiders) with identification to species level. Toxicon 2003; 42:163-171.
    25) Isbister GK & Hirst D: Injuries from spider spines, not spider bites. Vet Human Toxicol 2002; 44(6):339-342.
    26) Isbister GK: Acute conjunctival inflammation following contact with squashed spider contents. Am J Ophthalmol 2003; 136:563-564.
    27) Kani H, Ishida N, & Nakagima T: An analogue of Joro Spider toxin selectively suppressed hippocampal epileptic discharges induced by quisqualate. Brain Res 1992; 581:161-164.
    28) Kelley TD & Wasserman G: The dangers of pet tarantulas: Experience of the marseilles poison centre (editorial). Clin Toxicol 1998; 36:55-56.
    29) King LE Jr: Spider bites. Arch Dermatol 1987; 123:41-43.
    30) Lieberman P, Nicklas R, Randolph C, et al: Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol 2015; 115(5):341-384.
    31) Lieberman P, Nicklas RA, Oppenheimer J, et al: The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126(3):477-480.
    32) Majeski JA & Durst GG: Bite by the spider Herpyllus ecclesiaticus in South Carolina. Toxicon 1975; 13:377.
    33) NSW Health: Spiderbite. In: Snakebite and Spiderbite Clinical Management Guidelines, NSW Department of Health, Sydney, Australia, 2007, pp 45-57.
    34) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
    35) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    36) Nhachi CFB & Kasilo OMJ: Poisoning due to insect and scorpion stings/bites. Hum Exper Toxicol 1993; 12:123-125.
    37) Nieuwenhuys E: The demystification of the toxicity of spiders. Institute for Media and Communications Management. St Gallen, Switzerland. 2008. Available from URL: http://www.xs4all.nl/~ednieuw/Spiders/Nasty-Spiders/The%20demystification%20of%20the%20toxicity%20of%20spiders.pdf. As accessed 2009-01-16.
    38) Nowak RM & Macias CG : Anaphylaxis on the other front line: perspectives from the emergency department. Am J Med 2014; 127(1 Suppl):S34-S44.
    39) Parrish HM: Analysis of 460 fatalities from venomous animals in the United States. Am J Med Sci 1963; 245:129.
    40) Pascoe RR: The nature and treatment of skin conditions observed in horses in Queensland. Aust Vet J 1973; 49:35.
    41) Pase HA III & Jennings DT: Bite by the spider Trachelas volutus Gertsch (Araneae: Clubionidae). Toxicon 1978; 16:96-98.
    42) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
    43) Pincus SJ, Winkel KD, Hawdon GM, et al: Acute and recurrent skin ulceration after spider bite. Med J Aust 1999; 171:99-102.
    44) Product Information: diphenhydramine HCl intravenous injection solution, intramuscular injection solution, diphenhydramine HCl intravenous injection solution, intramuscular injection solution. Hospira, Inc. (per DailyMed), Lake Forest, IL, 2013.
    45) Redman JF: Human envenomation by a lycosid. Arch Dermatol 1974; 110:111-112.
    46) Rowland MD & Griffiths DW: The spider as a possible source of tularemia. JAMA 1988; 260:33.
    47) Russell FE & Gertsch WJ: For those who treat spider or suspected spider bites. Toxicon 1983; 21:337-339.
    48) Uetz GW: Envenomation by the spider Trachelas tranquillus (Hentz) (Araneae: Clubionidae). J Med Entomol 1973; 10:227.
    49) Vanden Hoek,TL; Morrison LJ; Shuster M; et al: Part 12: Cardiac Arrest in Special Situations 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. American Heart Association. Dallas, TX. 2010. Available from URL: http://circ.ahajournals.org/cgi/reprint/122/18_suppl_3/S829. As accessed 2010-10-21.
    50) Vetter RS, Isbister GK, Bush SP, et al: Verified bites by yellow sac spiders (genus Cheiracanthium) in the United States and Australia: where is the necrosis?. Am J Trop Med Hyg 2006; 74(6):1043-1048.
    51) Vetter RS: Envenomation by a spider, Agelenopsis aperta, (family: Agelenidae) previously considered harmless. Ann Emerg Med 1998; 32:739-741.
    52) White J, Hirst D, & Hender E: 36 cases of bites by spiders, including the white-tailed spider Lampona cylindrata. Med J Aust 1989; 150:401-403.
    53) Wong RC, Hughes SE, & Voorhees JJ: Spider bites. Arch Dermatol 1987; 123:98-104.
    54) Woo KML & Smart DR: The clinical effects of spider bites in southern Tasmania. Emerg Med 1999; 11:145-149.
    55) Yarbrough BE: Current treatment of brown recluse spider bites. Curr Concepts Wound Care 1987; Winter:4-6.